INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 78 filers reported holding INSTIL BIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,517,504 | -22.3% | 8,218,467 | 0.0% | 1.92% | +111.6% |
| Q2 2023 | $4,528,375 | -16.6% | 8,218,467 | 0.0% | 0.91% | -17.0% |
| Q1 2023 | $5,430,763 | +4.9% | 8,218,467 | 0.0% | 1.10% | -15.8% |
| Q4 2022 | $5,177,634 | -87.0% | 8,218,467 | 0.0% | 1.30% | -83.3% |
| Q3 2022 | $39,777,000 | +4.8% | 8,218,467 | 0.0% | 7.80% | +2.3% |
| Q2 2022 | $37,969,000 | -57.0% | 8,218,467 | 0.0% | 7.63% | -48.5% |
| Q1 2022 | $88,349,000 | -39.1% | 8,218,467 | -3.1% | 14.82% | -44.6% |
| Q4 2021 | $145,072,000 | -4.3% | 8,478,790 | 0.0% | 26.75% | +60.1% |
| Q3 2021 | $151,558,000 | -7.5% | 8,478,790 | 0.0% | 16.71% | -38.3% |
| Q2 2021 | $163,810,000 | -23.0% | 8,478,790 | 0.0% | 27.08% | -33.4% |
| Q1 2021 | $212,648,000 | – | 8,478,790 | – | 40.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
| CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
| VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
| Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
| Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
| Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
| RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
| Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
| HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
| Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |